GoodRx Holdings Statistics
Total Valuation
GoodRx Holdings has a market cap or net worth of $626.25 million. The enterprise value is $917.42 million.
Important Dates
The last earnings date was Wednesday, February 25, 2026, after market close.
| Earnings Date | Feb 25, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
GoodRx Holdings has 339.43 million shares outstanding. The number of shares has decreased by -8.98% in one year.
| Current Share Class | 105.47M |
| Shares Outstanding | 339.43M |
| Shares Change (YoY) | -8.98% |
| Shares Change (QoQ) | -2.03% |
| Owned by Insiders (%) | 3.87% |
| Owned by Institutions (%) | 18.52% |
| Float | 92.55M |
Valuation Ratios
The trailing PE ratio is 21.60 and the forward PE ratio is 12.14.
| PE Ratio | 21.60 |
| Forward PE | 12.14 |
| PS Ratio | 0.80 |
| Forward PS | 0.77 |
| PB Ratio | 1.10 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 3.87 |
| P/OCF Ratio | 3.79 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 5.31, with an EV/FCF ratio of 5.58.
| EV / Earnings | 30.14 |
| EV / Sales | 1.15 |
| EV / EBITDA | 5.31 |
| EV / EBIT | 10.49 |
| EV / FCF | 5.58 |
Financial Position
The company has a current ratio of 2.61, with a Debt / Equity ratio of 0.88.
| Current Ratio | 2.61 |
| Quick Ratio | 2.02 |
| Debt / Equity | 0.88 |
| Debt / EBITDA | 3.00 |
| Debt / FCF | 3.30 |
| Interest Coverage | 2.05 |
Financial Efficiency
Return on equity (ROE) is 4.54% and return on invested capital (ROIC) is 5.32%.
| Return on Equity (ROE) | 4.54% |
| Return on Assets (ROA) | 3.92% |
| Return on Invested Capital (ROIC) | 5.32% |
| Return on Capital Employed (ROCE) | 7.56% |
| Weighted Average Cost of Capital (WACC) | 8.70% |
| Revenue Per Employee | $1.08M |
| Profits Per Employee | $41,245 |
| Employee Count | 738 |
| Asset Turnover | 0.57 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, GoodRx Holdings has paid $26.10 million in taxes.
| Income Tax | 26.10M |
| Effective Tax Rate | 46.16% |
Stock Price Statistics
The stock price has decreased by -61.86% in the last 52 weeks. The beta is 1.50, so GoodRx Holdings's price volatility has been higher than the market average.
| Beta (5Y) | 1.50 |
| 52-Week Price Change | -61.86% |
| 50-Day Moving Average | 2.52 |
| 200-Day Moving Average | 3.64 |
| Relative Strength Index (RSI) | 33.98 |
| Average Volume (20 Days) | 3,912,280 |
Short Selling Information
The latest short interest is 10.81 million, so 3.19% of the outstanding shares have been sold short.
| Short Interest | 10.81M |
| Short Previous Month | 9.68M |
| Short % of Shares Out | 3.19% |
| Short % of Float | 11.68% |
| Short Ratio (days to cover) | 3.10 |
Income Statement
In the last 12 months, GoodRx Holdings had revenue of $796.85 million and earned $30.44 million in profits. Earnings per share was $0.09.
| Revenue | 796.85M |
| Gross Profit | 739.26M |
| Operating Income | 87.49M |
| Pretax Income | 56.54M |
| Net Income | 30.44M |
| EBITDA | 172.71M |
| EBIT | 87.49M |
| Earnings Per Share (EPS) | $0.09 |
Full Income StatementBalance Sheet
The company has $261.82 million in cash and $542.81 million in debt, with a net cash position of -$280.99 million or -$0.83 per share.
| Cash & Cash Equivalents | 261.82M |
| Total Debt | 542.81M |
| Net Cash | -280.99M |
| Net Cash Per Share | -$0.83 |
| Equity (Book Value) | 616.26M |
| Book Value Per Share | 1.81 |
| Working Capital | 397.10M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $167.90 million and capital expenditures -$3.52 million, giving a free cash flow of $164.38 million.
| Operating Cash Flow | 167.90M |
| Capital Expenditures | -3.52M |
| Free Cash Flow | 164.38M |
| FCF Per Share | $0.48 |
Full Cash Flow StatementMargins
Gross margin is 92.77%, with operating and profit margins of 10.98% and 3.82%.
| Gross Margin | 92.77% |
| Operating Margin | 10.98% |
| Pretax Margin | 7.10% |
| Profit Margin | 3.82% |
| EBITDA Margin | 21.67% |
| EBIT Margin | 10.98% |
| FCF Margin | 20.63% |
Dividends & Yields
GoodRx Holdings does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 8.98% |
| Shareholder Yield | 8.98% |
| Earnings Yield | 4.78% |
| FCF Yield | 25.83% |
Analyst Forecast
The average price target for GoodRx Holdings is $4.64, which is 151.49% higher than the current price. The consensus rating is "Buy".
| Price Target | $4.64 |
| Price Target Difference | 151.49% |
| Analyst Consensus | Buy |
| Analyst Count | 10 |
| Revenue Growth Forecast (5Y) | 6.17% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside | |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |
